๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The insulin-like growth factor system as a target in breast cancer

โœ Scribed by Douglas Yee


Publisher
Springer US
Year
1994
Tongue
English
Weight
1000 KB
Volume
32
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Insulin-like growth factor-1 receptors a
โœ John A. Foekens; Henk Portengen; Manon Janssen; Jan G. M. Klijn ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 915 KB

In the current study the authors have investigated whether human primary breast cancer specimens contain insulin-like growth factor-1 (IGF-1) receptors (IGF-1-R) or IGF-1-like activities. Simultaneously, epidermal growth factor (EGF) receptors (EGF-R) and cytosolic estrogen receptor (ER), progestero

Insulin resistance, insulin-like growth
โœ Ralph R. Kazer ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 591 KB

Consideration of existing data regarding clinical and biochemical risk factors for the development of breast cancer leads to the hypothesis that enhanced insulin-like growth factor I (IGF-I) activity plays a significant role in the development of this disease. Abnormal IGF-l activity may be related

Free insulin-like growth factor-I and br
โœ Benjamin D.L. Li; M. Javad Khosravi; Hans J. Berkel; Anastasia Diamandi; Mark A. ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 56 KB ๐Ÿ‘ 2 views

Insulin-like growth factor-I (IGF-I) has mitogenic and antiapoptotic effects on breast cancer cells. Epidemiologic studies have shown that high plasma levels of IGF-I and low levels of IGF binding protein (BP)-3 are associated with increased risk of breast cancer in premenopausal women. The actions